Responses
Clinical and epidemiological research
Extended report
Efficacy and safety of CT-P13 (biosimilar infliximab) in patients with rheumatoid arthritis: comparison between switching from reference infliximab to CT-P13 and continuing CT-P13 in the PLANETRA extension study
Compose a Response to This Article
Other responses
No responses have been published for this article.